Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 410 participants.
Also called NCT03192332
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 410 participants
- Registry
-
NCT03192332
-
- Other papers using this trial's data
- MRI vs CT for Baseline Imaging Evaluation in Acute Large Artery Ischemic Stroke: A Subanalysis of the SWIFT-DIRECT Trial
- SWIFT DIRECT: Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke: Methodology of a randomized, controlled, multicentre study
- Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria, Canada, Finland, France, Germany, Spain, Switzerland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03192332. Randomized; single masking; primary purpose treatment. Start 2017-11-29 (actual); primary completion 2021-05-14 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic Stroke
- Acronym
- SWIFT DIRECT
- Condition
- Ischemic Stroke
- Intervention (Device)
- Stent-retriever thrombectomy with revascularization device of the Solitaire™ type
- Intervention (Drug)
- Intravenous thrombolysis with recombinant tissue-type plasminogen activator (IV t-PA)
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Collaborator
- Medtronic
Record details
- Record id
cardio:ct-nct03192332- Content hash
797b245d502aa5e1891d0ca25e446f9e0713ce98c3e7dc5d94fb1d071ad2a591